Success Metrics

Clinical Success Rate
85.4%

Based on 205 completed trials

Completion Rate
85%(205/240)
Active Trials
21(7%)
Results Posted
54%(110 trials)
Terminated
35(12%)

Phase Distribution

Ph phase_1
15
5%
Ph phase_3
90
30%
Ph not_applicable
45
15%
Ph early_phase_1
4
1%
Ph phase_4
88
29%
Ph phase_2
55
18%

Phase Distribution

19

Early Stage

55

Mid Stage

178

Late Stage

Phase Distribution297 total trials
Early Phase 1First-in-human
4(1.3%)
Phase 1Safety & dosage
15(5.1%)
Phase 2Efficacy & side effects
55(18.5%)
Phase 3Large-scale testing
90(30.3%)
Phase 4Post-market surveillance
88(29.6%)
N/ANon-phased studies
45(15.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.3%

205 of 249 finished

Non-Completion Rate

17.7%

44 ended early

Currently Active

21

trials recruiting

Total Trials

304

all time

Status Distribution
Active(25)
Completed(205)
Terminated(44)
Other(30)

Detailed Status

Completed205
Terminated35
unknown29
Recruiting19
Withdrawn9
Not yet recruiting4

Development Timeline

Analytics

Development Status

Total Trials
304
Active
21
Success Rate
85.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (1.3%)
Phase 115 (5.1%)
Phase 255 (18.5%)
Phase 390 (30.3%)
Phase 488 (29.6%)
N/A45 (15.2%)

Trials by Status

recruiting196%
suspended10%
active_not_recruiting21%
terminated3512%
unknown2910%
withdrawn93%
completed20567%
not_yet_recruiting41%

Recent Activity

Clinical Trials (304)

Showing 20 of 304 trialsScroll for more
NCT07549490Not Applicable

Human Experimental Models of Pain (HEMP)

Not Yet Recruiting
NCT07157852Not Applicable

The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia

Recruiting
NCT05967052Phase 2

Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation

Terminated
NCT03216187Phase 3

Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery

Terminated
NCT06628908Phase 3

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Recruiting
NCT00891397Not Applicable

Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study)

Terminated
NCT07630753Not Applicable

Effect of Pregabalin on Optic Nerve Sheath Diameter in Craniotomy Patients.

Active Not Recruiting
NCT06049797

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Completed
NCT07567924Phase 4

Comparison Between Pregabalin and Acetaminophen for the Treatment of Post-Mastectomy Pain Syndrome

Completed
NCT06619860Phase 2

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

Recruiting
NCT07587645Not Applicable

Tapentadol vs Pregabalin for Postoperative Pain in Lower Limb Surgery

Completed
NCT07275762Phase 2

Y-4 to Treat the Postherpetic Neuralgia

Recruiting
NCT03794388Phase 3

Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery

Completed
NCT06614322Phase 2

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

Recruiting
NCT07451431Phase 4

Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain

Recruiting
NCT07421427Not Applicable

Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome

Recruiting
NCT07196657Not Applicable

The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With Fibromyalgia

Recruiting
NCT05488847Phase 4

Opioid-Free Pain Protocol After Shoulder Arthroplasty

Active Not Recruiting
NCT07389551Not Applicable

Comparison of Pregabalin Versus Gabapentin as Pre-emptive Analgesic

Completed
NCT07382921Not Applicable

Efficacy and Safety of Pregabalin/Tizanidine vs. Pregabalin in Patients With Fibromyalgia

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
304